Skip to main content
Bruce Miller, MD, Psychiatry, Buffalo, NY

BruceD.MillerMD

Psychiatry Buffalo, NY

Child & Adolescent Psychiatry

Professor, Psychiatry, SUNY Buffalo School of Medicine & Biomedical

Are you Dr. Miller?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 32 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    219 Bryant St
    Buffalo, NY 14222
    Phone+1 716-878-7645
    Fax+1 716-888-3935

Summary

  • Dr. Bruce Miller, MD is a board certified psychiatrist in Buffalo, New York. He is currently licensed to practice medicine in New York, Colorado, and New Jersey. He is affiliated with KALEIDA Health and is a Professor at SUNY Buffalo School of Medicine & Biomedical.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Child and Adolescent Psychiatry, 1979 - 1981
  • University of Colorado
    University of ColoradoResidency, Psychiatry, 1976 - 1979
  • Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside Hospital
    Zucker School of Medicine at Hofstra/Northwell at Zucker Hillside HospitalInternship, Transitional Year, 1972 - 1973
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1972

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License Current
  • NY State Medical License
    NY State Medical License 1973 - 2025
  • CO State Medical License
    CO State Medical License 1981 - 1991
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child Psychiatry

Publications & Presentations

PubMed

Press Mentions

  • The Use of Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers and Cognitive Decline in Alzheimer’s Disease: The Importance of Blood-Brain Barrier Penetration and APOE ε4 Carrier Status
    The Use of Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers and Cognitive Decline in Alzheimer’s Disease: The Importance of Blood-Brain Barrier Penetration and APOE ε4 Carrier StatusFebruary 11th, 2021
  • Dolby Family Gift Launches New UCSF Center for Mood Disorders
    Dolby Family Gift Launches New UCSF Center for Mood DisordersSeptember 18th, 2018
  • If You Treat a Parent's Depression, Will Their Child's Asthma Improve?
    If You Treat a Parent's Depression, Will Their Child's Asthma Improve?March 11th, 2016
  • Join now to see all